Iwaki, Hirotaka

Virus exposure and neurodegenerative disease risk across national biobanks

Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron

Multiple Sclerosis Research StudiesDementia and Cognitive Impairment Research

Cited by 341

The Parkinson's Disease Genome‐Wide Association Study Locus Browser

Grenn, F. P., Kim, J. J., Makarious, M. B., Iwaki, H., Illarionova, A., Brolin, K., Kluss, J. H., Schumacher‐Schuh, A. F., Leonard, H., Faghri, F., et al. (2020) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 92

A proteogenomic view of Parkinson’s disease causality and heterogeneity

Kaiser, S., Zhang, L., Mollenhauer, B., Jacob, J., Longerich, S., Del-Aguila, J., Marcus, J., Raghavan, N., Stone, D., Fagboyegun, O., et al. (2023) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsAdvanced Proteomics Techniques and Applications

Cited by 68

Genome-wide determinants of mortality and motor progression in Parkinson’s disease

Tan, M. M. X., Lawton, M. A., Pollard, M. I., Brown, E., Real, R., Carrasco, A. M., Bekadar, S., Jabbari, E., Reynolds, R. H., Iwaki, H., et al. (2024) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 17

Cerebrospinal Fluid Neopterin, but not Osteopontin, is a Valuable Biomarker for the Treatment Response in Patients with HTLV-I-associated Myelopathy

Nagai, M., Tsujii, T., Iwaki, H., Nishikawa, N., & Nomoto, M. (2013) · Internal Medicine

T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis

Cited by 10